Pharmaceutical Logistics Market: Cold Chain Imperatives

1
Pharmaceutical Logistics Market Cold Chain
Imperatives According to Inkwood Research, the
global pharmaceutical logistics market is
expected to progress at a CAGR of 7.56 over the
forecast period 2024 to 2032. Cold chain
logistics is pivotal in pharmaceutical logistics,
ensuring the safe and effective transportation of
temperature-sensitive products.
Companies are making substantive progress within
the cold chain by incorporating energy-efficient
refrigeration, implementing emission-reducing
transport routes, and utilizing eco-friendly
packaging. The COVID-19 pandemic has influenced
the transformation of pharmaceutical logistics
globally. This transformation is evident with a
focus on strategic initiatives by
companies post-COVID. Further, a concerted
effort is being made to reinforce cold chain
infrastructure by investing in temperature-control
led storage facilities and enhancing last-mile
delivery networks. These efforts signify an
advancement in transporting pharmaceutical
products with a strong focus on environmental
sustainability. Request a FREE sample of the
Pharmaceutical Logistics Market Optimal Cold
Chain Performance in Pharmaceutical Logistics
Market Cold chain logistics is an indispensable
aspect of pharmaceutical logistics,
ensuring the secure transportation of
temperature-sensitive drugs and
2
vaccines. This specialized system meticulously
controls temperatures throughout the supply
chain, from production to end-user
delivery. Market Position According to Inkwood
Research, cold chain logistics is anticipated to
be the fastest-growing type, with a CAGR of 8.51
in the global market. Various companies, such as
Ember LifeSciences and USADA, specialize in cold
chain logistics. They ensure the safe transport
of temperature-sensitive goods like
pharmaceuticals and food products. These
companies offer end-to- end solutions, from
storage to transportation, maintaining product
integrity throughout the supply
chain. Accordingly, Ember LifeSciences and the
US Anti-Doping Agency (USADA) have collaborated
to improve blood-sample shipping efficiency for
the 2024 US Olympic Team Trials. Embers cold
chain technology focuses on self- contained,
self-monitoring shipping systems for
temperature-sensitive pharmaceuticals, vaccines,
and lab specimens. The Ember Cube provides an
integrated solution to common cold chain shipping
challenges, ensuring secure transport and
preserved efficacy of medical items. USADA has
previously used the Ember Cube at multiple 2023
sporting events. This encompasses events like the
Boston and New York Marathons and the Ironman
World Championship in Hawaii. Further, the
Cubes cloud-based dashboard allowed real-time
monitoring of location and temperatures, ensuring
optimal conditions for blood samples during
transit. This partnership addresses shipment
delays and offers a cost- effective, reusable
shipping solution. It includes advanced features
like self- refrigeration and integrated
temperature monitoring, enhancing overall
efficiency and reliability in healthcare
logistics. Sustainability as a Strategic
Mandate Pharmaceutical Logistics Market
Sustainability stands as a foundational element
in modern pharmaceutical logistics, exerting a
substantial impact on industry practices and
strategic operations. With increasing global
attention on Environmental, Social, and
Governance (ESG) standards, sustainability has
evolved into a crucial determinant for
pharmaceutical companies. Accordingly, Maersks
proactive cold chain solutions are
revolutionizing pharmaceutical logistics by
reducing GHG emissions and enhancing
sustainability in cargo transport. It is
committed to the Science Based Targets initiative
(SBTI), which aims for net-zero emissions by 2040
in alignment with the Paris Agreement. As global
regulations on ESG standards tighten, the
pharmaceutical industry is redefining its value
chain for sustainability.
3
In response to the urgent need for sustainable
logistics solutions, Maersk developed the
groundbreaking Pharma Cold Chain Management
(PCCM) solution. This comprehensive offering
ensures seamless real-time monitoring and swift
intervention in case of cold container
malfunctions. It also adheres strictly to Good
Distribution Practice (GDP) standards. Further,
Maersks ECO Delivery Ocean product reduces GHG
emissions and costs by transitioning from air to
sea freight. This shift underlines pharmaceutical
logistics domain commitment to sustainability
and empowers the demand to meet ambitious
emission reduction targets. Get CUSTOMIZED
market insights delivered right to your
inbox! Post COVID-19 Resilience Pharmaceutical
Logistics Market Pharmaceutical logistics faced
unprecedented challenges during COVID-19, notably
with the rapid distribution of vaccines. The
scale was immense, with over 13 billion doses
administered globally and 70 of the worlds
population receiving at least one
dose. Logistics providers like Nippon Express
played an important role during the COVID-19
vaccination campaign. They chartered grounded
passenger flights and utilized cold storage
containers with masses of dry ice to maintain
temperature-controlled conditions. This was
crucial for vaccines like mRNA, which necessitate
ultra-low temperatures, including some as low as
minus 70 degrees Celsius. In response to
evolving industry trends, theres a noticeable
transition towards specialized medicines and
stricter regulations such as GDP standards. This
paradigm is shaping the future of pharmaceutical
logistics, prompting companies like Nippon
Express to enhance their capabilities. The
company has invested in infrastructure, including
the establishment of four major GDP-certified
warehouses in Japan. Its also developed a
comprehensive network comprising 35
GDP-certified stations across 25 countries. These
initiatives emphasize the pharmaceutical logistics
commitment to ensuring compliance and
maintaining high-quality standards throughout the
supply chain. Moreover, Nippon Express is
actively pursuing sustainability initiatives
within pharmaceutical logistics. Their focus is
on developing reusable materials for cold chain
transport, advancing real-time monitoring
technologies, and implementing standardized
quality controls globally. Apart from these
advancements made by Nippon Express, several other
companies have provided ongoing assistance in
pharmaceutical logistics, both
4

• during and post-COVID. These contributions have
  been essential in ensuring the efficient
  distribution of vaccines, medications, and
  medical supplies.
• Here are some notable contributions by key
  companies in the pharmaceutical logistics sector
  post-COVID
• Cardinal HealthCardinal Health collaborated with
  healthcare providers and manufacturers to ensure
  the uninterrupted supply of essential medical
  products post-COVID, implementing resilient
  logistics strategies.
• Cencora (AmerisourceBergen)The company employed
  innovative logistics strategies post-COVID to
  address supply chain challenges and meet
  increased demand for healthcare products
  efficiently.
• LogiNextLogiNext leveraged data analytics and
  AI-driven optimization tools to streamline supply
  chain operations and reduce transit times. This
  enhanced inventory management, enabling better
  responsiveness to market fluctuations and
  ensuring continuous supply chain flow.
• Flipkart and AmazonMajor players like Flipkart
  and Amazon expanded their healthcare logistics
  services. This included temperature-controlled
  warehousing and specialized delivery networks to
  support the increased demand for pharmaceutical
  products through e-commerce platforms.
• Gati-KWEThe company expanded its cold chain
  capabilities, investing in technology to improve
  real-time tracking and temperature control. This
  ensured the safe and efficient delivery of
  pharmaceutical products, especially vaccines and
  critical medications.
• The convergence of sustainable cold chain
  practices, heightened by the demands of COVID-era
  pharmaceutical logistics, has become a catalyst
  for market evolution. Major players like Flipkart
  and Amazon, alongside innovative companies, have
  expanded cold chain capabilities and employed
  advanced technologies, ensuring the efficient
  delivery of critical medications.
• This sustainable approach meets the urgent demand
  for pharmaceutical products and fosters
  resilience in supply chains globally. With
  progressions in the supply chain laying a
  foundation for continued growth and adaptability
  in healthcare logistics, the pharmaceutical
  logistics market is predicted to observe
  developing growth during the forecast period.

5

• FAQs
• Why is pharmaceutical logistics important?
• A Pharmaceutical logistics is crucial for
  maintaining the integrity and efficacy of
  medications, especially temperature-sensitive
  products like vaccines and biologics. It ensures
  that medicines reach patients and healthcare
  facilities promptly and in optimal condition.
• What technologies are used in pharmaceutical
  logistics?
• A Pharmaceutical logistics uses technologies
  such as cold chain monitoring systems, RFID
  (Radio-Frequency Identification) tracking,
  GPS-enabled logistics, data analytics, and
  blockchain to enhance visibility, traceability,
  efficiency, and compliance throughout the supply
  chain.